首页> 中文期刊> 《中德临床肿瘤学杂志(英文版) 》 >Ⅱ型VLDLR上调VEGF、MMP2和MMP7的表达促乳腺癌细胞迁移(英文)

Ⅱ型VLDLR上调VEGF、MMP2和MMP7的表达促乳腺癌细胞迁移(英文)

         

摘要

Objective: Very low density lipoprotein receptor (VLDLR) has been considered as a multiple function receptor due to binding numerous ligands, causing endocytosis and regulating cellular signaling. Our group previously reported that type Ⅱ VLDLR overexpression in breast cancer tissues. The purpose of this study is to characterize type Ⅱ VLDLR activities during cell migration using breast cancer cell lines. Methods: Western blotting was used to test protein expression. Cell migration was analyzed by Scratch wound assay. The mRNA expression was tested by realtime-PCR. Reporter assay was to test the transcription activity. Results: Scratch wound and Report assay indicated up-regulated VLDLR Ⅱ expression promotes cell migration via activating Wnt/β-catenin pathway. The target genes such as VEGF, MMP2 and MMP7 were upregulated in VLDLR Ⅱ overexpressed cells. On the contrary, cells treated with TFPI had an inhibition effect of cell migration response to down-regulation of VLDLR Ⅱ. Conclusion: Type Ⅱ VLDLR conferred a migration and invasion advantage by activating Wnt/β-catenin pathway, then up-regulating VEGF, MMP2 and MMP7 in breast cancer cells.

著录项

  • 来源
    《中德临床肿瘤学杂志(英文版) 》 |2013年第8期|374-378|共5页
  • 作者

    Lei He; Yanjun Lu; Jianli Guo;

  • 作者单位

    1. Department of Blood Transfusion;

    Tongji Hospital;

    Tongji Medical College;

    Huazhong University of Science and Technology 2. Clinical Laboratory;

    Tongji Hospital;

    Tongji Medical College;

    Huazhong University of Science and Technology 3. Department of Biochemis;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 乳腺肿瘤 ;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号